Patent details

EP2272868 Title: Combination therapy for B cell disorders

Basic Information

Publication number:
EP2272868
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP100094168
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Combination therapy for B cell disorders
French Title of Invention:
Thérapie de combinaison pour des désordres de cellules B
German Title of Invention:
Kombinationstherapie für B-Zell-Erkrankungen
SPC Number:

Dates

Filing date:
04/06/2004
Grant date:
04/03/2015
EP Publication Date:
04/03/2015
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/01/2011
EP B1 Publication Date:
04/03/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
04/06/2024
Renunciation date:
Revocation date:
20/04/2021
Annulment date:

Owner

From:
04/06/2004
 
 

Name:
GENENTECH, INC.
Address:
1 DNA WAY, SOUTH SAN FRANCISCO CA 94080-4990, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
03/06/2015
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Chan Andrew
Address:
United States (US)

2

Name:
Gong Qian
Address:
United States (US)

3

Name:
Martin Flavius
Address:
United States (US)

Priority

1

Priority Number:
476414 P
Priority Date:
05/06/2003
Priority Country:
United States (US)

2

Priority Number:
476481 P
Priority Date:
05/06/2003
Priority Country:
United States (US)

3

Priority Number:
476531 P
Priority Date:
06/06/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 16/00;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2022/02
Publication date:
01/02/2022
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

Issue number:
202204
Publication date:
26/01/2022
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
14/05/2021
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
262 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages